Figure 3.
VIP-differentiated DCs generate human regulatory T cells in vitro. Purified naive CD4 T cells exposed to allogeneic DCcontrols (Treg controls) or DCVIPs (Treg VIPs) were evaluated for suppressive/regulatory activity. (A) Treg VIPs (□) or Treg controls (▪) were cocultured at different ratios with syngeneic TH1 cells in the presence of allogeneic mature DCs (mDCs). Proliferation of T cells and IL-2 production was determined. Treg VIPs, alone or with allogeneic mDCs, did not proliferate. (B) TH1 cells and Treg VIPs were generated by priming of CD4 T cells from donor C with allogeneic DCcontrols or DCVIPs from donor A (TH1anti-A/Treg VIPsanti-A) or donor B (TH1anti-B/Treg VIPsanti-B) and were cocultured in the presence of mDCs from donor A or donor B, or both, as indicated. Proliferation of responder T cells was determined. Each result is the mean ± SD of 3 experiments performed in duplicate. (C) Polarized TH1 cells were cocultured with Treg VIPs and allogeneic mDCs in the presence or absence of blocking anti-IL-10, anti-TGFβ, anti-CTLA-4, or IL-2 antibody. Additionally, TH1 + mDCs were separated from Treg VIPs+mDCs in a Transwell system. The proliferative response of TH1 cells was determined. (D) Phenotype of Treg VIPs and Treg controls. Expression of surface markers (CD25, CD69, CD70, CD154), intracellular IL-10 and CTLA-4, and cytosolic and membrane-bound TGFβ were determined by flow cytometry. Numbers represent the percentage of positive cells in each quadrant. Foxp3 and neuropilin 1 (Nrp1) mRNA expression in sorted CD4+, CD4+CD25+, and CD4+CD25- Treg controls (▪) or Treg VIPs (□) was determined by real-time RT-PCR. Results are representative of 5 independent experiments.